Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Agnieszka Razim und 25 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienn…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Administration, Intranasal, Escherichia coli, Probiotics. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowa Agencja Wymiany Akademickiej, OP JAK project MSCA fellowships CZ-UK2, Grantová Agentura České Republiky.
Abstract (Originalsprache)
Escherichia coli A0 34/86 (EcO83) is a probiotic strain used in newborns to prevent nosocomial infections and diarrhoea. This bacterium stimulates both pro‐ and anti‐inflammatory cytokine production and its intranasal administration reduces allergic airway inflammation in mice. Despite its benefits, there are concerns about the use of live probiotic bacteria due to potential systemic infections and gene transfer. Extracellular vesicles (EVs) derived from EcO83 (EcO83‐EVs) might offer a safer alternative to live bacteria. This study characterizes EcO83‐EVs and investigates their interaction with host cells, highlighting their potential as postbiotic therapeutics. EcO83‐EVs were isolated, purified, and characterised following the Minimal Information of Studies of Extracellular Vesicles (MISEV) guidelines. Ex vivo studies conducted in human nasal epithelial cells showed that EcO83‐EVs increased the expression of proteins linked to oxidative stress and inflammation, indicating an effective interaction between EVs and the host cells. Further in vivo studies in mice demonstrated that EcO83‐EVs interact with nasal‐associated lymphoid tissue, are internalised by airway macrophages, and stimulate neutrophil recruitment in the lung. Mechanistically, EcO83‐EVs activate the NF‐κΒ signalling pathway, resulting in the nitric oxide production. EcO83‐EVs demonstrate significant potential as a postbiotic alternative to live bacteria, offering a safer option for therapeutic applications. Further research is required to explore their clinical use, particularly in mucosal vaccination and targeted immunotherapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
- Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
- Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Division of Neonatology, Paediatric Intensive Care and Neuropediatric, Department of Paediatrics and Adolescent Medicine, Comprehensive Centre for Paediatrics, Medical University of Vienna, Vienna, Austria.
- Department of Medical Physics, M. Smoluchowski Institute of Physics, Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, Krakow, Poland.
ORCID-Profile: Agnieszka Razim, Bradley Whitehead, Mattia Morandi, Marco Brucale, Irma Schabussova
Förderung
- Narodowa Agencja Wymiany Akademickiej
- OP JAK project MSCA fellowships CZ-UK2
- Grantová Agentura České Republiky
- Amt der NÖ Landesregierung
- OeAD-GmbH
- Vienna Science and Technology Fund
- SciMat and qLife Priority Research Area under Strategic Programme Excellence Initiative "Laboratories for the Young"
- Austrian Science Fund
Zitieren
APA
Razim, A., Zabłocka, A., Schmid, A., Thaler, M., Černý, V., Weinmayer, T., Whitehead, B., Martens, A., Skalska, M., Morandi, M., Schmidt, K., Wysmołek, M. E., Végvári, A., Srutkova, D., Schwarzer, M., Neuninger, L., Nejsum, P., Hrdý, J., Palmfeldt, J., …, & Schabussova, I. (2024). Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70004
Vancouver
Razim A, Zabłocka A, Schmid A, Thaler M, Černý V, Weinmayer T, et al. Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.70004
BibTeX
@article{Razim2024,
author = {Razim, Agnieszka and Zabłocka, Agnieszka and Schmid, Anna and Thaler, Michael and Černý, Viktor and Weinmayer, Tamara and Whitehead, Bradley and Martens, Anke and Skalska, Magdalena and Morandi, Mattia and Schmidt, Katy and Wysmołek, Magdalena E and Végvári, Akos and Srutkova, Dagmar and Schwarzer, Martin and Neuninger, Lukas and Nejsum, Peter and Hrdý, Jiri and Palmfeldt, Johan and Brucale, Marco and Valle, Francesco and Górska, Sabina and Wisgrill, Lukas and Inic-Kanada, Aleksandra and Wiedermann, Ursula and Schabussova, Irma},
title = {Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.70004}
}
EUVIMED